Pharmaceutical Industry Information Portal

HomeNews

News

Biogen invests $120 million in MedRhythms, a music therapy for multiple sclerosis

Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment...

PepGen announces pricing of initial public stock offering

PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...

FDA restricts J&J’s COVID-19 vaccine on blood clot risks

The Food and Drug Administration is limiting the use of the J&J shot, which received U.S. clearance in February 2021. In a statement released on...

EuroAPI, split from Sanofi, rises after stock market debut

EuroAPI, Sanofi’s pharmaceutical-ingredients spinoff, rose on its first trading day in Paris, in an early sign that appetite is recovering in Europe’s dormant listings...

BMS, Merck enter into $2.3 billion partnership with Amphista to discover and develop small molecule protein degraders

Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, May 4th announced a strategic collaboration...

AmerisourceBergen, Cardinal Health and McKesson agree to opioid settlement up to $518 million

Washington has reached a $518 million settlement with drug distributors McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc, ending a months-long trial over the...
spot_img

Expert Articles

spot_img